1. نشرة وزارة الصحة للتلفاست اقراص ١٢٠ مجم و ١٨٠ مجم بتاريخ ٢٩-١١-٢٠١٨

2. Cauwenberge V, STAR STUDY INVESTIGATING GROUP. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis. Clinical & Experimental Allergy. 2000 Jun;30(6):891-9.

3. Meltzer EO, Casale TB, Nathan RA, Thompson AK. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. Annals of Allergy, Asthma & Immunology. 1999 Oct 1;83(4):311-7. (Edited)

4. Compalati E, Baena-Cagnani R, Penagos M, Badellino H, Braido F, Gómez RM, Canonica GW, Baena-Cagnani CE. Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. International archives of allergy and immunology. 2011;156(1):1-5.

5. Hampel F, Ratner P, Mansfield L, Meeves S, Liao Y, Georges G. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis. Annals of Allergy, Asthma & Immunology. 2003 Oct 1;91(4):354-61.